Immunologic targets in psoriasis

N Engl J Med. 2003 Nov 20;349(21):1987-90. doi: 10.1056/NEJMp038164.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Psoriasis / drug therapy*
  • Psoriasis / immunology*
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Etanercept
  • efalizumab